@DrTranBioSci when all the smoke clears $CLVS can easily hit mid 20s. Head to head it is better, and going against giants $MRK and $AZN, at least in prostrate. Now the question is why is market not seeing the value here. Am I missing something? Big pharma(s) should be jumping to buy this.